InVivoSIM anti-human 4-1BB (Urelumab Biosimilar)

Catalog #SIM0058
Clone:
Urelumab
Reactivities:
Human, Monkey

$235.00 - $8,140.00

$235.00 - $8,140.00

Choose an Option...
  • 100 mg - $8,140.00
  • 50 mg - $4,574.00
  • 25 mg - $3,182.00
  • 5 mg - $911.00
  • 1 mg - $235.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Details

This non-therapeutic biosimilar antibody uses the same variable regions as the therapeutic antibody, Urelumab, making it ideal for research use. Urelumab reacts with 4-1BB, also known as CD137 antigen, TNF receptor superfamily member 9, or induced by lymphocyte activation. Urelumab has been engineered as a humanized IgG4 monoclonal antibody to reduce its non-specific binding to Fc receptors. Urelumab has a hinge mutation, S228P, which prevents IgG4 Fab exchange, thereby improving stability. CD137 is a type 1 membrane glycoprotein receptor that belongs to the tumor necrosis factor (TNF) superfamily, and it is expressed in lymphoid tissues. Upon activation, CD137 is expressed on the surface of several immune cells, including T cells (CD4+ and CD8+), NKT cells, regulatory T cells, eosinophils, and dendritic cells. Notably, CD137 is not expressed on the surface of resting T and B cells, as well as activated B lymphocytes, rendering it an advantageous biomarker for immunological activation. CD137L is an established ligand of CD137, and the CD137-CD137L signaling pathway augments and prolongs T-cell reactivity to alloantigens. Urelumab is an agonistic antibody that replicates cross-linking by the endogenous ligand (i.e., CD137-CD137L), and this antibody triggers a robust costimulatory signal in antigen-primed T cells, enhances the ADCC of NK cells, and boosts the T cell-mediated antitumor immunity.

Specifications

Isotype Human IgG1, Īŗ
Recommended Isotype Control(s) RecombiMAb human IgG4 (S228P) isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Mutations S228P
Immunogen Human 4-1BB (CD137)
Reported Applications in vivo 4-1BB stimulation
in vitro 4-1BB stimulation
Functional assays
Immunoprecipitation
Flow cytometry
ELISA
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin <0.5EU/mg (<0.0005EU/μg)
Determined by LAL gel clotting assay
Aggregation <5%
Determined by SEC
Purity >95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein A
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.